Richu Sharma,Shivali Sharma
Heart failure affects more than 40 million people globally in a single year and is expected to increase in the coming time. In patients, who have associated co-morbidities are more likely to develop left ventricular dysfunction and subsequently heart failure. Left ventricular dysfunction increases cardiovascular mortality and morbidity in end stage renal disease patients on hemodialysis. Peritoneal dialysis has emerged as an alternative mode of renal replacement therapy for end stage renal disease patients. However the prevalence of left ventricular dysfunction in end stage renal disease patients is scarcely known. A 33.33% prevalence of left ventricular dysfunction has been observed in our study.
